483 Antares Pharma Dec 2018

483 Antares Pharma Dec 2018

Susan Matthias FDA$119.00 - Available Now

FDA investigators audited the Antares Pharma - Minneapolis, MN, United States facility and issued inspectional observations (via FDA 483) on 04 Dec 2018.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 04 Dec 2018
  • Location: Minneapolis, United States
  • FEI: 2182861
Add To Cart